TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance

U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
33.23-0.24 (-0.72%)
At close: 4:01PM EST

33.26 0.03 (0.09%)
After hours: 7:08PM EST

People also watch
MYLNVSGILDAMGNABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close33.47
Open33.42
Bid0.00 x
Ask0.00 x
Day's Range33.16 - 33.57
52 Week Range33.16 - 64.31
Volume8,442,885
Avg. Volume10,350,687
Market Cap33.73B
Beta0.47
PE Ratio (TTM)22.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.36 (3.99%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopedia7 hours ago

    JP Morgan Downgrades Teva

    JP Morgan cut Teva price target and rating today. What are the options to spur growth in the coming quarters?

  • Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER
    Insider Monkeyyesterday

    Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER

    Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try. They will now be able to use Vantreal ER (hydrocodone bitartrate), which has gained the approval of the US Food and Drug Administration (FDA). The drug from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is suitable for daily management of […]

  • Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval
    Zacksyesterday

    Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval

    Teva Pharmaceutical Industries Ltd. (TEVA) announced that the FDA has approved Vantrela ER for the treatment of pain which is severe enough to require daily, around-the-clock, long-term opioid treatment.